RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.060
0.00 (0.00%)
At close: May 12, 2025, 4:00 PM
1.060
0.00 (0.00%)
After-hours: May 12, 2025, 5:19 PM EDT
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $38.74 million as of May 12, 2025. Its market cap has increased by 33.35% in one year.
Market Cap
38.74M
Enterprise Value
31.86M
1-Year Change
33.35%
Ranking
Category
Stock Price
$1.06
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $38.74M, a decrease of -43.56%. That is a compound annual growth rate of -14.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 38.74M | 25.12% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |